Solventum (SOLV) Total Non-Current Liabilities (2023 - 2026)
Solventum (SOLV) posted Total Non-Current Liabilities of $8.6 billion for Q1 2026, down 0.55% on a QoQ basis from $8.7 billion in Q4 2025, and down 21.26% year-over-year from $11.0 billion in Q1 2025.
Solventum (SOLV) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends
Solventum's Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $8.6 billion for Q1 2026.
- Quarterly Total Non-Current Liabilities fell 21.26% year-over-year to $8.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 billion (down 21.26% YoY) and the FY2025 annual result came in at $8.7 billion, down 21.55% from the prior year.
- Total Non-Current Liabilities was $8.6 billion for Q1 2026 at Solventum, down from $8.7 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $11.4 billion in Q2 2024 and bottomed at $2.1 billion in Q4 2023.
- A 4-year average of $9.4 billion and a median of $10.8 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities surged 421.79% — and 2025, when it slipped 23.99%.
- Solventum's Total Non-Current Liabilities stood at $2.1 billion in 2023, then jumped by 421.79% to $11.1 billion in 2024, then dropped by 21.55% to $8.7 billion in 2025, then retreated by 0.55% to $8.6 billion in 2026.
- Business Quant data shows SOLV's Total Non-Current Liabilities at $8.6 billion in Q1 2026, $8.7 billion in Q4 2025, and $8.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 12.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.65 Bn |
| Dec 31, 2025 | 8.70 Bn |
| Sep 30, 2025 | 8.55 Bn |
| Jun 30, 2025 | 11.06 Bn |
| Mar 31, 2025 | 10.99 Bn |
| Dec 31, 2024 | 11.09 Bn |
| Sep 30, 2024 | 11.25 Bn |
| Jun 30, 2024 | 11.41 Bn |
| Mar 31, 2024 | 10.69 Bn |
| Dec 31, 2023 | 2.13 Bn |